Frontlight ResearchEarly access
Trial site
APHP – Hôpitaux Universitaire Henri Mondor
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Crohn's disease1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Lupus (SLE)1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 11 trial
- Phase 31 trial
- Phase 41 trial
- Status
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- CRISPR Therapeutics AG1 trial
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives1 trial
- Kura Oncology, Inc.1 trial
Running trials
Recruiting
Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Crohn's disease1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Lupus (SLE)1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026